Bone mineral density screening and its accordance with Canadian clinical practice guidelines from 2000–2013: an unchanging landscape in Saskatchewan, Canada

McLeod, Katherine M.; Johnson, Shanthi; Charturvedi, Rahul; St.Onge, Jennifer; Lionel, Amrita; Verma, Ashok Kumar

doi:10.1007/s11657-015-0227-2

Cited by 4 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9 The strong relationship between low bone mass and risk of fracture has been well documented. 3,[10][11][12][13][14] Whereas osteoporosis in postmenopausal women is a well-recognized and extensively investigated health problem, there is a paucity of research on the effects of osteoporosis for older men. As a result, male osteoporosis remains largely underdiagnosed and undertreated.…”

Section: Estimate the Current Burden Of Illness Of Osteoporosis Inmentioning

confidence: 99%

Optimizing osteoporosis care in a rural primary health care center: Findings of a research study aimed to support seniors

et al. 2019

View full text Add to dashboard Cite

Background Osteoporosis is one of the most under‐diagnosed and under‐treated health conditions in Canada. This study questioned whether an invitation to self‐refer for osteoporosis risk evaluation would improve the number of patients who were tested for bone mineral density (BMD) at a rural Primary Health Care Center (PHCC). Purpose The purpose of this study is to improve osteoporosis care and decrease bone fracture risk in a population of patients 65 years of age and older. Methodology A quasi‐experimental research design was used to review screening rates of BMD testing and identified patients in this population who were at low, moderate, and high risk for developing osteoporosis. Screening rates at the PHCC were compared to screening rates at another rural PHCC in the province. Conclusion The self‐referral program for BMD testing and a nurse‐led intervention resulted in an increased number of people who were BMD tested at the study PHCC compared with the control PHCC, and identified more male patients 65 years of age and older who were at risk for osteoporosis and bone fractures. Recommendations suggest future research in other provincial PHCCs that may encourage self‐referral programs for BMD testing and improved osteoporosis care for patients 65 years of age and older.

show abstract

Section: Estimate the Current Burden Of Illness Of Osteoporosis Inmentioning

confidence: 99%

Optimizing osteoporosis care in a rural primary health care center: Findings of a research study aimed to support seniors

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Therefore, effective strategies to reduce the incidence of fracture are urgently required. In recent years, the problem of osteoporosis has received increasing attention worldwide (7)(8)(9).…”

Section: Introductionmentioning

confidence: 99%

Acupoint injection treatment for primary osteoporosis: a systematic review and meta-analysis of randomized controlled trials

Huang

et al. 2019

Ann. Palliat. Med.

View full text Add to dashboard Cite

Background: Acupoint injection has currently received increasing attention as a treatment for primary osteoporosis (POP), This study aimed to evaluate the efficacy and safety of acupoint injection as a clinical treatment for POP.Methods: Randomized controlled trials (RCTs) of acupoint injection compared with conventional nonacupoint injection for POP were identified in searches of seven databases from their inception to March 2019. All data were assessed and extracted by two authors independently. The risk of bias assessment recommended by the Cochrane Collaboration was used to assess the quality of the selected studies. RevMan 5.3 was used to conduct meta-analysis for the efficacy and safety of acupoint injection.Results: Five trials with 337 patients (aged 45-86 years) with bone mineral density (BMD) ≤2 SD were included in our meta-analysis. The results showed that, compared with conventional intramuscular injection, acupoint injection significantly increased the BMD [mean difference (MD) =0.02; 95% CI, 0.01 to 0.03, P<0.00001]. Subgroup analysis indicated that acupoint injection significantly improved lumbar BMD (MD =0.02; 95% CI, 0.01 to 0.03, P<0.00001) but did not reduce the pain score (SMD =−2.29, 95% CI, −6.81 to 2.23, P>0.05). Individuals results showed that acupoint injection improved biochemical indicators, such as NBAP, IGF-I and reduced CTX and leptin levels. While the risk of bias was high in all five trials.Conclusions: This meta-analysis and systematic review suggests that acupoint injection improves BMD and some biochemical indicators in POP patients compared with the effects of conventional intramuscular injection. However, due to the high risk of bias in all the trials reviewed, the evidence remains inconclusive and future research will be required with improved methodological quality.

show abstract

Acupoint injection treatment for primary osteoporosis

Huang

et al. 2019

Medicine

View full text Add to dashboard Cite

show abstract

Bone mineral density screening and its accordance with Canadian clinical practice guidelines from 2000–2013: an unchanging landscape in Saskatchewan, Canada

Abstract: The burden of osteoporosis remains high and largely unchanged in Saskatchewan, Canada. These results serve to inform strategies to enhance health-care provider awareness and compliance with practice guidelines, as well as improve screening rates and patient health behaviors.

Cited by 4 publications

References 19 publications

Optimizing osteoporosis care in a rural primary health care center: Findings of a research study aimed to support seniors

Optimizing osteoporosis care in a rural primary health care center: Findings of a research study aimed to support seniors

Acupoint injection treatment for primary osteoporosis: a systematic review and meta-analysis of randomized controlled trials

Acupoint injection treatment for primary osteoporosis

Contact Info

Product

Resources

About